A Randomized Comparison of Granisetron Plus Dexamethason with Granisetron alone for the Control of Acute Chemotherapy-Induced Emesis and Nausea
,
Abstract
Introduction: Chemotherapeutic drugs used to treat cancer may cause nausea and emesis by inducing the release of 5-hydroxytryptamine (5-HT) in the small intestine. Blockage of 5-HT3 receptors in the small intestine by 5-HT3 receptor antagonists might prevent the nausea and vomiting associated with chemotherapy for cancer. The aim of this study was to compare the efficacy and tolerability of the 5-HT3 receptor antagonists (granisetron) and granisetron plus dexamethasone in the treatment of acute chemotherapy induced digestive emesis and nausea.
Materials and Methods: Patients on their first course of emetic chemotherapy (cisplation or doxorubicin based regimen) were randomly placed into two treatment groups. Group A received a one-time administration of granisetron 3 mg, IV and group B received granisetron plus dexamethasone 8 mg IV. For each study the drug were administered one time, 30 minutes before infusion of chemotherapy emetic agent. For the efficacy assessment, response data were recorded every 6 hours for a total of 24 hours, after the start of the chemotherapy infusion.
Results: A total of 138 patients [86 males, 52 females with amean age of 48 (a range between 15-82 years)] were involved in the study . Of these, 125 were evaluable.
Discussion: The ability of granisetron plus dexamethason to prevent acute emesis was significantly better than, administering granisetron alone (66.7% vs 42.8% respectively) (p<0.001). The combination of granisetron and low-dose dexamethasone is superior to granisetron alone to control acute emetic episodes in patients receiving emetogenic chemotherapy.
Millev AD, Monaka S. Mechanism of Vomiting in Due by Serotonin Receptor Agonist in the Cat: Effect of Vagotomy, Splanchnicectomy or Postrema lesions. J Pharmaco Exp Ther. 1992; 260: 509-516.
Komoto T, Ito H, Nagakor. Mechanisms of Cisplatin and m Clorophenil Guanide Induced Emesis in Felrets. Eur J Pharmacal. 1993; 239: 369-376.
O’Brein BJ, Rusthoven J, Rocchi A, et al. Impact of Chemotherapy Associated Nausea and Vomiting on Patients Functional Status and on Costs, Survey of Five Canadian Center. UK. 1993: 149. 296-302.
Andrews PL. The Pharmacologic Profile of Granisetron (Kytril). Semin Oncol, 1994, 21: 3-9.
Perez EA, Gardara DR. The Clinical Role of Granisetron in the Prevention of Chemotherapy induced Emesis. Semin Oncol. 1994; 21: 15-21.
Heron JF, Coedhals I, Jordan JP, et al. Oral Granisetron Alone and in Combination with Dexamethazon: Double– Blind- Randomized Comparison Metoclopramid plus Dexamethason in Prevention of Cisplatin– Induced Emesis. Ann Oncol 1994; 5: 579-584.
Latrelle J, Stewart D, Laberg F, et al. Dexamethason Improves the Efficacy of Granisetron in the First 24 hours Following High Dose Cisplatin Chemotherapy. Support Care Cancer 1995; 3: 307-312.
Van Bell SJ, Cocyuyt VF, Bleibery H, etal. Combination Therapy with Novoban in Patients with Incomplete Control of Chemotherapy– Induced Nausea and Vomiting . Anti- Cancer Drug. 1995; 6: 22-30.
Chuang –Chi L, Ceng-Hsu W, Hsien –Kun C, et al. Prevention of Acute and Delayed Cisplatin Induced Nausea and Vomiting with IV Ondansetron plus IV Dexamethasone. Chang Gung Med J. 2000; 23: 413-9.
Parry H, Martin K. Single Dose IV Dexamethasone an Effective Anti-Emetic in Cancer Chemotherapy.Cancer Chemotherapy & Pharmacology. 1991; 28(3): 231-2.
Aapro MS, Thuerlimann B, Sessa C, et al. A Randomized Double–Blind Trial to Compare the Clinical Efficacy of Granisetron with Metoclopramide, both Combind with Dexamethasone in the Prophylaxis of Chemotherapy–Induced Delayed Emesis. Annals of Oncology. 2003; 14: 291-297.
Hesketh PJ, Crews R, Cohene R, et al. Antiemetic Efficacy of Single–Dose Oral Granisetron (1mg, 2mg) with Moderately Emetogenic Chemotherapy. Cancer J Sci Am, 2000; 6: 157-166.
By the Italian Group for Antiemetic Research. Double– Blined, Dose–Finding Study of Four IV Dose of Dexamethasone in the Prevention of Cisplatin-Induced Acute Emesis. Italian Group for Antiemetic Research. J Clin Oncol. 1998; 16: 2937-2942.
Kris MG, Crall RJ, Tyson LB ,et al. Controlling Delayed Vomiting Double–Blind, Randomized Trial Comparing Placebo. Dexamethasone Alone and Metoclopramid plus Dexamethasone in Patients Receiving Cisplatin. J Clin Oncol, 1989; 7: 108-114.
Tsukada H, Hirose T, Yokoyama A, et al. Randomised Comparison of Ondansetron plus Dexamethasone with Dexamethasone Alone for Control of Delayed Cisplatin- Induced Emesis. European Journal of Cancer, 2001. 37: 2398- 2404.
Smith DB, Newlands ES, Rustin GJ, et al. Comparison of Ondansetron and Ondansetron plus Dexamethasonen as Antiemetic Prophylaxis During Cisplatin-Containing Chemotherapy. Lancet, 1991. 338 (8765): 487-90.
Alvarez O, Freeman A, Bedros A, etal. Randomized Double-Blind Crossover Ondansetron-Dexamethasone versus Ondansetron-Placebo Study for the Treatment of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients with Malignancies. Journal of pediatric hematology/oncology, 1995. 17(2): 145-500.
| Files | ||
| Issue | Vol 3, No 2 (2009) | |
| Section | Articles | |
| Keywords | ||
| Nausea Vomiting Chemotherapy Granisetron Dexamethasone | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
